Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Long-Term Debt Repayments (2016 - 2018)

Niagen Bioscience (NAGE) has disclosed Long-Term Debt Repayments for 6 consecutive years, with -$47000.0 as the latest value for Q2 2018.

  • Quarterly Long-Term Debt Repayments fell 166.2% to -$47000.0 in Q2 2018 from the year-ago period, while the trailing twelve-month figure was -$47000.0 through Sep 2019, down 202.17% year-over-year, with the annual reading at $565000.0 for FY2019, N/A changed from the prior year.
  • Long-Term Debt Repayments for Q2 2018 was -$47000.0 at Niagen Bioscience, down from $47000.0 in the prior quarter.
  • The five-year high for Long-Term Debt Repayments was $424000.0 in Q3 2017, with the low at -$47000.0 in Q2 2018.
  • Average Long-Term Debt Repayments over 3 years is $83485.0, with a median of $55901.0 recorded in 2016.
  • The sharpest move saw Long-Term Debt Repayments soared 658.48% in 2017, then crashed 166.2% in 2018.
  • Over 3 years, Long-Term Debt Repayments stood at $57733.0 in 2016, then decreased by 20.32% to $46000.0 in 2017, then crashed by 202.17% to -$47000.0 in 2018.
  • According to Business Quant data, Long-Term Debt Repayments over the past three periods came in at -$47000.0, $47000.0, and $46000.0 for Q2 2018, Q1 2018, and Q4 2017 respectively.